Pneumonia diagnosis

Fujifilm India Introduces AI Software for COVID-19 Pneumonia Diagnosis

Fujifilm India has partnered with Bangalore-based multi-specialty private healthcare provider Sakra World Hospital to launch new AI-enabled software to help doctors diagnose COVID-19 pneumonia.

WHAT HE DOES

The COVID-19 Pneumonia Image Analysis Program automatically analyzes the chest CT images and displays the results. It includes the Fujifilm SYNAPSE 3D Image Archiving and Communication System, a workstation system that views and analyzes 3D images from CT scans and MRI scans.

WHY IS IT IMPORTANT

COVID-19 pneumonia, according to Johns Hopkins Medicine section, tends to affect both lungs of a patient. The air sacs in the lungs can become filled with fluid, limiting their ability to absorb oxygen and causing shortness of breath, coughing, and other symptoms. “While most people recover from pneumonia without any lasting lung damage, pneumonia associated with COVID-19 can be serious,” the article said. The lung damage caused by the disease can lead to difficulty breathing that can last for months.

Fujifilm said there is an “urgent” need for solutions that support efficient testing and accurate diagnostic imaging, especially for patients with “post-COVID lung management issues.”

MARKET OVERVIEW

One of India’s oldest medical schools, Andhra Medical College, recently tested a new AI platform that is also capable of assessing the lung health of a COVID-19 patient. the Salcit Technologies’ Swaasa technology uses machine learning to perform audiometric analysis of cough sounds, as well as temperature, oxygen saturation and symptoms.

Indian AI startup for health Endimension also has an AI-based clinical support tool called ENDIM-AI-CXR which detects COVID-19 patterns from chest x-rays. Recently, he acquired 23 million rupees (over $ 300,000) in seed funding to expand his business.

ON THE RECORD

“With our new technology, we aim to reduce the burden on healthcare workers who have been at the forefront of the fight against COVID-19,” said Koji Wada, Managing Director of Fujifilm India.

“With this new AI technology, we hope to empower our healthcare professionals to combat such complications. We thank Fujifilm India for joining us and strengthening Indian healthcare infrastructure with new innovations, ”also said Yuichi Nagano, general manager of Sakra World Hospital.